CXCL2 (MIP-2α) can promote the disruption of the BBB by inducing endothelial cell activation and neutrophil recruitment, potentially leading to the extravasation of blood components and water, culminating in HT and vasogenic brain edema (Chen et al., 2021). Here, CXCL2 is linked to hematocrit.